Our primary objective is to assess the effects (benefits and harms) of ECT for people with treatment-resistant schizophrenia.
Our secondary objectives are to determine whether ECT produces a differential response in people:
- who are treated with unilateral compared to bilateral ECT;
- who have had a long course of ECT (more than 12 sessions) or short course of ECT;
- who are given continuation or maintenance ECT;
- who are diagnosed with well defined treatment resistant schizophrenia as opposed to less rigorously defined treatment-resistant schizophrenia (who would be expected to have a greater affective component to their illness).
This is a protocol.